Scientists hunt clues to why blood cancer patients face higher heart risks
NCT ID NCT06692894
Summary
This study aims to understand why people with myelodysplastic syndromes (MDS), a type of blood cancer, have a higher risk of heart problems like heart disease and stroke. Researchers will follow 30 adult MDS patients for 6 months, collecting small blood samples to measure inflammation markers. The goal is to identify proteins that might help predict cardiovascular risks in this patient group, potentially leading to better monitoring and management strategies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROMES, ADULT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Vermont
RECRUITINGBurlington, Vermont, 05495-2038, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.